Oral stops

The first important category of sounds are known as oral stops. In English, stops occur in voiced/unvoiced pairs, so that [b] and [p] use the same manner and place and of articulation, and differ only as to whether the glottis is vibrating or not. The three nasals (the last sounds in THEM, THIN and thing) are often also described as nasal stops. While it is possible to continuously utter these three phones, they usually follow the pattern of the stop in normal speech, with a closure and... 

The first SRS-A antagonist, FPL-55712 (26) (149), was discovered before the stmctures of the leukotrienes were detemiined. Although this compound is relatively weak as an antagonist and suffers from a very short half-life in vivo, it played an important role both in leukotriene stmcture elucidation and as a model for later antagonists. In work stmcturaHy related to FPL-55712, LY-171883 was developed (27) (150). LY-171883 was evaluated in several clinical trials before development was stopped. Orally adrninistered, LY-171883 blocked slightly the response to aerosol LTD improved pulmonary function (FEV ) in mild asthmatics (151), decreased the sensitivity of asthmatics to cold air-induced bronchoconstriction (152), and significantly reduced the bronchoconstrictor response to inhaled antigen (153). However, in all these studies the beneficial effects were minimal. 

Figure 15.4 The central and peripheral metabolism of levodopa and its modification by drugs, (a) Levodopa alone. After oral administration alone most dopa is rapidly decarboxylated to DA in the gut and blood with some o-methylated (COMT) to o-methyl/dopa (OMD). Only a small amount (3%) enters the CNS to be converted to DA. (b) After an extracerebral dopa decarboxylase inhibitor. Blocking just the peripheral dopa decarboxylase (DD) with inhibitors like carbidopa and benserazide, that cannot enter the CNS (extra cerebral dopa decarboxylase inhibitors, ExCDDIs), stops the conversion of levodopa to DA peripherally, so that more enters the CNS or is o-methylated peripherally to OMD.

ANSWER I think that elearly it is possible that there is no neurotoxieity in humans. I think all of us would like for this to be the ease. And maybe it is the ease. We have talked about this a lot with fenfluramine, and we have done studies with paraehloroamphetamine in whieh we have given it orally to rats at relatively low doses, but still anoreetie doses, over 90 days. We have seen depletion of serotonin, but that was fully reversible depletion. It eame baek when the drug was stopped. I think there may be no neurotoxieity at the oral doses used in humans. I think that would be great if that is the ease. That would explain why there is no depression or other kinds of symptoms. But I don t feel comfortable about relying on the laek of reporting of depression as real evidence that there is no neurotoxieity. We simply need to have better data on that. 

Metronidazole (Flagyl) Antenatal Steroids 2 g orally once Safe during pregnancy. During lactation, temporarily stop breast-feeding for 12-24 hours. 

---